• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Voyager Therapeutics (VYGR)

Common Shares
Sell: $3.88|Buy: $3.99|Change: 0.13 (3.37%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associatedvirus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous,or IV, dosing. Its segment is developing and commercializing genetic medicine.

Address

75 Sidney Street
Cambridge
MA
USA
02139

Telephone

+1 857 2013463

Website

https://www.voyagertherapeutics.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Voyager Therapeutics Inc Fourth Quarter Earnings Results for 20262027-03-09T00:00:00
Voyager Therapeutics Inc Annual Report for 20262027-03-09T00:00:00
Voyager Therapeutics Inc Third Quarter Earnings Results for 20262026-11-10T00:00:00
Voyager Therapeutics Inc Second Quarter Earnings Results for 20262026-08-06T00:00:00
Voyager Therapeutics Inc Annual General Meeting for 20262026-06-03T11:00:00
Voyager Therapeutics Inc First Quarter Earnings Results for 20262026-05-06T00:00:00

Previous key dates

NameKey Date
Stifel 2026 CNS Days2026-03-18T12:30:00
Leerink Global Healthcare Conference 20262026-03-10T10:40:00
Voyager Therapeutics Inc Annual Report for 20252026-03-09T00:00:00
Voyager Therapeutics Inc Fourth Quarter Earnings Results for 20252026-03-09T00:00:00
TD Cowen 46th Annual Health Care Conference2026-03-02T13:10:00
Oppenheimer 36th Annual Healthcare Life Sciences Conference2026-02-26T15:20:00
Guggenheim Emerging Outlook: Biotech Summit 20262026-02-11T13:00:00
Stifel 2025 Healthcare Conference2025-11-11T15:20:00
Voyager Therapeutics Inc Third Quarter Earnings Results for 20252025-11-10T00:00:00
Baird's Biotech Discovery Series: Voyager Therapeutics Conference2025-10-01T13:30:00
H.C. Wainwright 27th Annual Global Investment Conference2025-09-09T14:30:00
Baird 2025 Global Healthcare Conference2025-09-09T09:05:00
Morgan Stanley 23rd Annual Global Healthcare Conference2025-09-08T00:00:00
Cantor Global Healthcare Conference 20252025-09-04T13:35:00
2025 Wells Fargo Healthcare Conference2025-09-03T16:30:00
Citi's 2025 Biopharma Back to School Conference2025-09-02T16:00:00
Voyager Therapeutics Inc Second Quarter Earnings Results for 20252025-08-06T00:00:00
H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference.2025-06-17T07:00:00
Voyager Therapeutics Inc Annual General Meeting for 20252025-06-03T11:00:00
Voyager Therapeutics Inc First Quarter Earnings Result for 20252025-05-06T00:00:00
Voyager and KOL AD/PD™ 2025 Recap2025-04-07T16:30:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.